Cargando…

The development and validation of a novel outcome measure to quantify mobility in the dysvascular lower extremity amputee: the amputee single item mobility measure

OBJECTIVE: This study describes the development and psychometric evaluation of a novel patient-reported single-item mobility measure. DESIGN: Prospective cohort study. SETTING: Four Veteran’s Administration Medical Centers. SUBJECTS: Individuals undergoing their first major unilateral lower extremit...

Descripción completa

Detalles Bibliográficos
Autores principales: Norvell, Daniel C, Williams, Rhonda M, Turner, Aaron P, Czerniecki, Joseph M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978165/
https://www.ncbi.nlm.nih.gov/pubmed/27496697
http://dx.doi.org/10.1177/0269215516644308
_version_ 1782447154226266112
author Norvell, Daniel C
Williams, Rhonda M
Turner, Aaron P
Czerniecki, Joseph M
author_facet Norvell, Daniel C
Williams, Rhonda M
Turner, Aaron P
Czerniecki, Joseph M
author_sort Norvell, Daniel C
collection PubMed
description OBJECTIVE: This study describes the development and psychometric evaluation of a novel patient-reported single-item mobility measure. DESIGN: Prospective cohort study. SETTING: Four Veteran’s Administration Medical Centers. SUBJECTS: Individuals undergoing their first major unilateral lower extremity amputation; 198 met inclusion criteria; of these, 113 (57%) enrolled. INTERVENTIONS: None. MAIN MEASURES: The Amputee Single Item Mobility Measure, a single item measure with scores ranging from 0 to 6, was developed by an expert panel, and concurrently administered with the Locomotor Capabilities Index-5 (LCI-5) and other outcome measures at six weeks, four months, and 12 months post-amputation. Criterion and construct validity, responsiveness, and floor/ceiling effects were evaluated. Responsiveness was assessed using the standardized response mean. RESULTS: The overall mean 12-month Amputee Single Item Mobility Measure score was 3.39 ±1.4. Scores for transmetatarsal, transtibial, and transfemoral amputees were 4.2 (±1.3), 3.2 (±1.5), and 2.9 (±1.1), respectively. Amputee Single Item Mobility Measure scores demonstrated “large” and statistically significant correlations with the LCI-5 scores at six weeks (r = 0.72), four months (r = 0.81), and 12 months (r = 0.86). At four months and 12 months, the correlation between Amputee Single Item Mobility Measure scores and hours of prosthetic use were r = 0.69 and r = 0.66, respectively, and between Amputee Single Item Mobility Measure scores and Trinity Amputation and Prosthesis Experience Scales functional restriction scores were r = 0.45 and r = 0.67, respectively. Amputee Single Item Mobility Measure scores increased significantly from six weeks to 12 months post-amputation. Minimal floor/ceiling effects were demonstrated. CONCLUSIONS: In the unilateral dysvascular amputee, the Amputee Single Item Mobility Measure has strong criterion and construct validity, excellent responsiveness, and does not exhibit floor/ceiling effects.
format Online
Article
Text
id pubmed-4978165
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-49781652016-08-18 The development and validation of a novel outcome measure to quantify mobility in the dysvascular lower extremity amputee: the amputee single item mobility measure Norvell, Daniel C Williams, Rhonda M Turner, Aaron P Czerniecki, Joseph M Clin Rehabil Articles OBJECTIVE: This study describes the development and psychometric evaluation of a novel patient-reported single-item mobility measure. DESIGN: Prospective cohort study. SETTING: Four Veteran’s Administration Medical Centers. SUBJECTS: Individuals undergoing their first major unilateral lower extremity amputation; 198 met inclusion criteria; of these, 113 (57%) enrolled. INTERVENTIONS: None. MAIN MEASURES: The Amputee Single Item Mobility Measure, a single item measure with scores ranging from 0 to 6, was developed by an expert panel, and concurrently administered with the Locomotor Capabilities Index-5 (LCI-5) and other outcome measures at six weeks, four months, and 12 months post-amputation. Criterion and construct validity, responsiveness, and floor/ceiling effects were evaluated. Responsiveness was assessed using the standardized response mean. RESULTS: The overall mean 12-month Amputee Single Item Mobility Measure score was 3.39 ±1.4. Scores for transmetatarsal, transtibial, and transfemoral amputees were 4.2 (±1.3), 3.2 (±1.5), and 2.9 (±1.1), respectively. Amputee Single Item Mobility Measure scores demonstrated “large” and statistically significant correlations with the LCI-5 scores at six weeks (r = 0.72), four months (r = 0.81), and 12 months (r = 0.86). At four months and 12 months, the correlation between Amputee Single Item Mobility Measure scores and hours of prosthetic use were r = 0.69 and r = 0.66, respectively, and between Amputee Single Item Mobility Measure scores and Trinity Amputation and Prosthesis Experience Scales functional restriction scores were r = 0.45 and r = 0.67, respectively. Amputee Single Item Mobility Measure scores increased significantly from six weeks to 12 months post-amputation. Minimal floor/ceiling effects were demonstrated. CONCLUSIONS: In the unilateral dysvascular amputee, the Amputee Single Item Mobility Measure has strong criterion and construct validity, excellent responsiveness, and does not exhibit floor/ceiling effects. SAGE Publications 2016-08-04 2016-09 /pmc/articles/PMC4978165/ /pubmed/27496697 http://dx.doi.org/10.1177/0269215516644308 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Articles
Norvell, Daniel C
Williams, Rhonda M
Turner, Aaron P
Czerniecki, Joseph M
The development and validation of a novel outcome measure to quantify mobility in the dysvascular lower extremity amputee: the amputee single item mobility measure
title The development and validation of a novel outcome measure to quantify mobility in the dysvascular lower extremity amputee: the amputee single item mobility measure
title_full The development and validation of a novel outcome measure to quantify mobility in the dysvascular lower extremity amputee: the amputee single item mobility measure
title_fullStr The development and validation of a novel outcome measure to quantify mobility in the dysvascular lower extremity amputee: the amputee single item mobility measure
title_full_unstemmed The development and validation of a novel outcome measure to quantify mobility in the dysvascular lower extremity amputee: the amputee single item mobility measure
title_short The development and validation of a novel outcome measure to quantify mobility in the dysvascular lower extremity amputee: the amputee single item mobility measure
title_sort development and validation of a novel outcome measure to quantify mobility in the dysvascular lower extremity amputee: the amputee single item mobility measure
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978165/
https://www.ncbi.nlm.nih.gov/pubmed/27496697
http://dx.doi.org/10.1177/0269215516644308
work_keys_str_mv AT norvelldanielc thedevelopmentandvalidationofanoveloutcomemeasuretoquantifymobilityinthedysvascularlowerextremityamputeetheamputeesingleitemmobilitymeasure
AT williamsrhondam thedevelopmentandvalidationofanoveloutcomemeasuretoquantifymobilityinthedysvascularlowerextremityamputeetheamputeesingleitemmobilitymeasure
AT turneraaronp thedevelopmentandvalidationofanoveloutcomemeasuretoquantifymobilityinthedysvascularlowerextremityamputeetheamputeesingleitemmobilitymeasure
AT czernieckijosephm thedevelopmentandvalidationofanoveloutcomemeasuretoquantifymobilityinthedysvascularlowerextremityamputeetheamputeesingleitemmobilitymeasure
AT norvelldanielc developmentandvalidationofanoveloutcomemeasuretoquantifymobilityinthedysvascularlowerextremityamputeetheamputeesingleitemmobilitymeasure
AT williamsrhondam developmentandvalidationofanoveloutcomemeasuretoquantifymobilityinthedysvascularlowerextremityamputeetheamputeesingleitemmobilitymeasure
AT turneraaronp developmentandvalidationofanoveloutcomemeasuretoquantifymobilityinthedysvascularlowerextremityamputeetheamputeesingleitemmobilitymeasure
AT czernieckijosephm developmentandvalidationofanoveloutcomemeasuretoquantifymobilityinthedysvascularlowerextremityamputeetheamputeesingleitemmobilitymeasure